ecteinascidin 743 has been researched along with Colorectal Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouvet, M; Han, Q; Hoffman, RM; Singh, SR; Sun, YU; Tan, Y; Ye, J; Zhao, M; Zhu, G | 1 |
| Bouvet, M; Clary, B; Han, Q; Hoffman, RM; Singh, SR; Sun, YU; Tan, Y; Ye, J; Zhao, M; Zhu, G | 1 |
| Berger, W; Englinger, B; Ferk, F; Grusch, M; Heffeter, P; Keppler, BK; Knasmüller, S; Körner, W; Lötsch, D; Mair, M; Miklos, W; Mohr, T; Pirker, C; van Schoonhoven, S | 1 |
| Alfaro, V; Casado, E; Cubedo, R; Díaz-Rubio, E; García, M; Gómez, J; Gravalos, C; Izquierdo, MA; Paz-Ares, L; Rivera-Herreros, F; Tabernero, J | 1 |
1 trial(s) available for ecteinascidin 743 and Colorectal Cancer
| Article | Year |
|---|---|
Phase II study of trabectedin in pretreated patients with advanced colorectal cancer.
Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dioxoles; Disease Progression; Female; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Prognosis; Salvage Therapy; Survival Rate; Tetrahydroisoquinolines; Time Factors; Trabectedin | 2007 |
3 other study(ies) available for ecteinascidin 743 and Colorectal Cancer
| Article | Year |
|---|---|
Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Body Weight; Cell Proliferation; Colorectal Neoplasms; Disease Models, Animal; Fluorouracil; Humans; Mice; Mice, Nude; Oxaliplatin; Trabectedin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Camptothecin; Colorectal Neoplasms; Fluorouracil; Green Fluorescent Proteins; Humans; Leucovorin; Mice; Mice, Nude; Mice, Transgenic; Random Allocation; Trabectedin; Tumor Burden; Xenograft Model Antitumor Assays | 2019 |
Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance.
Topics: Cell Line, Tumor; Cisplatin; Colorectal Neoplasms; Cullin Proteins; Dioxoles; DNA Repair; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Genes, p53; HCT116 Cells; Humans; RNA, Small Interfering; Tetrahydroisoquinolines; Trabectedin | 2017 |